Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome To report the toxicity and pathologic response rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results